Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Auffret

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Therapie|April 18, 2015
[Drug Shortage May Have Serious Outcome: the French Exemple of Phenytoine]Marine Auffret, Louise Tyvaert, Marie-Laure Laroche, et al.
Fundamental & Clinical Pharmacology|November 21, 2015
Safety profile of etifoxine: A French pharmacovigilance surveyJudith Cottin, Aurore Gouraud, Marie-Josèphe Jean-Pastor, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 18, 2022
Gabapentinoid-induced peripheral edema and acute heart failure: A translational study combining pharmacovigilance data and in vitro animal experimentsBérenger Largeau, Romain Bordy, Côme Pasqualin, et al.
Fundamental & Clinical Pharmacology|May 28, 2014
Bullous pemphigoid induced by vildagliptin: a report of three casesJohana Béné, Aurélie Jacobsoone, Patrick Coupe, et al.
Therapie|December 26, 2022
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Expert Opinion on Drug Safety|December 18, 2016
Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocolBenjamin Rolland, Marine Auffret, Julien Labreuche, et al.
Therapie|December 10, 2014
[Temporary recommendation for use on off-label baclofen: viewpoint of Prescribers of the CAMTEA system]Benjamin Rolland, Sylvie Deheul, Thierry Danel, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Therapie|April 18, 2015
[Drug Shortage May Have Serious Outcome: the French Exemple of Phenytoine]Marine Auffret, Louise Tyvaert, Marie-Laure Laroche, et al.
Fundamental & Clinical Pharmacology|November 21, 2015
Safety profile of etifoxine: A French pharmacovigilance surveyJudith Cottin, Aurore Gouraud, Marie-Josèphe Jean-Pastor, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 18, 2022
Gabapentinoid-induced peripheral edema and acute heart failure: A translational study combining pharmacovigilance data and in vitro animal experimentsBérenger Largeau, Romain Bordy, Côme Pasqualin, et al.
Fundamental & Clinical Pharmacology|May 28, 2014
Bullous pemphigoid induced by vildagliptin: a report of three casesJohana Béné, Aurélie Jacobsoone, Patrick Coupe, et al.
Therapie|December 26, 2022
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Expert Opinion on Drug Safety|December 18, 2016
Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocolBenjamin Rolland, Marine Auffret, Julien Labreuche, et al.
Therapie|December 10, 2014
[Temporary recommendation for use on off-label baclofen: viewpoint of Prescribers of the CAMTEA system]Benjamin Rolland, Sylvie Deheul, Thierry Danel, et al.
Pageof 4